Biotech · Private company
Resolve Therapeutics
Track this companyFree. Adds Resolve Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- RSLV-132Phase 2 · Post-acute Corona Virus 19 (COVID-19) (Long COVID)ClinicalTrials.gov · fetched Nov 12, 2026
- RSLV-132Phase 2 · Primary Sjögren SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- RSLV-132Phase 2 · Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- Sodium Chloride 0.9%Phase 2 · Post-acute Corona Virus 19 (COVID-19) (Long COVID)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of RSLV-132 in Females With Sjögren's DiseasePHASE2 · ACTIVE_NOT_RECRUITING · started Dec 1, 2024ClinicalTrials.gov NCT06440525 · fetched Nov 12, 2026
- Phase 2 Study of RSLV-132 in Subjects With Long COVIDPHASE2 · COMPLETED · started Jun 25, 2021ClinicalTrials.gov NCT04944121 · fetched Nov 12, 2026
- A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)PHASE2 · COMPLETED · started Jan 3, 2016ClinicalTrials.gov NCT02660944 · fetched Nov 12, 2026